David V. Glidden

31.5k total citations · 5 hit papers
283 papers, 17.2k citations indexed

About

David V. Glidden is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, David V. Glidden has authored 283 papers receiving a total of 17.2k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Infectious Diseases, 80 papers in Epidemiology and 51 papers in Virology. Recurrent topics in David V. Glidden's work include HIV/AIDS Research and Interventions (99 papers), HIV Research and Treatment (51 papers) and HIV, Drug Use, Sexual Risk (49 papers). David V. Glidden is often cited by papers focused on HIV/AIDS Research and Interventions (99 papers), HIV Research and Treatment (51 papers) and HIV, Drug Use, Sexual Risk (49 papers). David V. Glidden collaborates with scholars based in United States, Canada and Peru. David V. Glidden's co-authors include Eric Vittinghoff, Steven P. Miller, Donna M. Ferriero, A. James Barkovich, Charles E. McCulloch, Stephen C. Shiboski, Robert M. Grant, Shannon E. G. Hamrick, Daniel B. Vigneron and Vanessa McMahan and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

David V. Glidden

272 papers receiving 16.8k citations

Hit Papers

Regression Methods in Biostatistics: Linear, Logistic, Su... 2006 2026 2012 2019 2006 2012 2007 2015 2012 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David V. Glidden United States 70 4.9k 4.8k 4.0k 3.6k 1.5k 283 17.2k
Stephen R. Cole United States 72 3.8k 0.8× 3.3k 0.7× 1.5k 0.4× 1.8k 0.5× 1.2k 0.8× 447 23.2k
A. E. Ades United Kingdom 69 5.1k 1.0× 2.8k 0.6× 1.3k 0.3× 3.3k 0.9× 946 0.6× 282 29.6k
Thomas Perneger Switzerland 72 2.9k 0.6× 4.2k 0.9× 939 0.2× 2.5k 0.7× 794 0.5× 346 25.0k
Mads Melbye Denmark 84 6.9k 1.4× 2.2k 0.5× 3.1k 0.8× 1.6k 0.5× 852 0.6× 535 24.1k
Richard Harding United Kingdom 75 2.6k 0.5× 2.2k 0.5× 7.1k 1.8× 5.9k 1.6× 312 0.2× 738 22.4k
Douglas K Owens United States 85 6.4k 1.3× 3.0k 0.6× 1.4k 0.3× 6.3k 1.8× 853 0.6× 344 34.3k
J. Dik F. Habbema Netherlands 73 3.1k 0.6× 3.2k 0.7× 2.6k 0.6× 2.7k 0.7× 199 0.1× 312 19.8k
Javier Zamora Spain 65 2.6k 0.5× 1.3k 0.3× 2.7k 0.7× 1.7k 0.5× 392 0.3× 311 15.1k
Charles Poole United States 55 3.1k 0.6× 1.4k 0.3× 1.3k 0.3× 1.6k 0.4× 291 0.2× 190 20.0k
Kristian Thorlund Canada 54 3.7k 0.7× 1.7k 0.4× 898 0.2× 2.8k 0.8× 283 0.2× 147 20.9k

Countries citing papers authored by David V. Glidden

Since Specialization
Citations

This map shows the geographic impact of David V. Glidden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David V. Glidden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David V. Glidden more than expected).

Fields of papers citing papers by David V. Glidden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David V. Glidden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David V. Glidden. The network helps show where David V. Glidden may publish in the future.

Co-authorship network of co-authors of David V. Glidden

This figure shows the co-authorship network connecting the top 25 collaborators of David V. Glidden. A scholar is included among the top collaborators of David V. Glidden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David V. Glidden. David V. Glidden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guan, Alice, Paul Wesson, David V. Glidden, et al.. (2025). LGB (lesbian, gay, and bisexual) state policy protections and substance use disparities. Health Affairs Scholar. 3(3). qxaf029–qxaf029.
2.
Beavers, Craig J., Alice K. Pau, David V. Glidden, et al.. (2025). Statin Therapy as Primary Prevention for Persons With HIV: A Synopsis of Recommendations From the U.S. Department of Health and Human Services Antiretroviral Treatment Guidelines Panel. Annals of Internal Medicine. 178(6). 847–857. 4 indexed citations
3.
Zyl, Gert U. van, Eric Decloedt, Lauren Jennings, et al.. (2025). A Real-Time Urine Tenofovir Assay Improves Drug Adherence Among People With HIV With Prior Virologic Failure in a Randomized Controlled Trial. Clinical Infectious Diseases. 81(5). e352–e359.
4.
Gandhi, Monica, David V. Glidden, Deepalika Chakravarty, et al.. (2024). Impact of a point-of-care urine tenofovir assay on adherence to HIV pre-exposure prophylaxis among women in Kenya: a randomised pilot trial. The Lancet HIV. 11(8). e522–e530. 8 indexed citations
5.
Tymofiyeva, Olga, Tracy Luks, Elissa J. Hamlat, et al.. (2024). Interoceptive brain network mechanisms of mindfulness-based training in healthy adolescents. Frontiers in Psychology. 15. 1410319–1410319. 1 indexed citations
6.
Al-Shoaibi, Abubakr A A, Iris Yuefan Shao, Kyle T. Ganson, et al.. (2024). Prospective association of screen time with binge‐eating disorder among adolescents in the United States: The mediating role of depression. International Journal of Eating Disorders. 57(5). 1192–1201. 5 indexed citations
7.
8.
Digitale, Jean, Jeffrey N. Martin, David V. Glidden, & M. Maria Glymour. (2023). Key concepts in clinical epidemiology: collider-conditioning bias. Journal of Clinical Epidemiology. 161. 152–156. 8 indexed citations
9.
Anderson, Peter L., Mark A. Marzinke, & David V. Glidden. (2023). Updating the Adherence–Response for Oral Emtricitabine/Tenofovir Disoproxil Fumarate for Human Immunodeficiency Virus Pre-Exposure Prophylaxis Among Cisgender Women. Clinical Infectious Diseases. 76(10). 1850–1853. 17 indexed citations
10.
Mody, Aaloke, Khai Hoan Tram, David V. Glidden, et al.. (2021). Novel Longitudinal Methods for Assessing Retention in Care: a Synthetic Review. Current HIV/AIDS Reports. 18(4). 299–308. 8 indexed citations
11.
Lee, Janet Y., Courtney Finlayson, Johanna Olson-Kennedy, et al.. (2020). Low Bone Mineral Density in Early Pubertal Transgender/Gender Diverse Youth: Findings From the Trans Youth Care Study. Journal of the Endocrine Society. 4(9). bvaa065–bvaa065. 41 indexed citations
12.
Drain, Paul K., Kenneth Ngure, Nelly Mugo, et al.. (2019). Testing a Real-Time Tenofovir Urine Adherence Assay for Monitoring and Providing Feedback to Preexposure Prophylaxis in Kenya (PUMA): Protocol for a Pilot Randomized Controlled Trial. SHILAP Revista de lepidopterología. 9(4). e15029–e15029. 15 indexed citations
13.
Zhang, Ye, Songyuan Tang, Katherine Li, et al.. (2019). Quantitative evaluation of an innovation contest to enhance a sexual health campaign in China. BMC Infectious Diseases. 19(1). 10 indexed citations
14.
Sikazwe, Izukanji, Ingrid Eshun‐Wilson, Kombatende Sikombe, et al.. (2019). Retention and viral suppression in a cohort of HIV patients on antiretroviral therapy in Zambia: Regionally representative estimates using a multistage-sampling-based approach. PLoS Medicine. 16(5). e1002811–e1002811. 43 indexed citations
15.
Janes, Holly, Marshall Brown, David V. Glidden, et al.. (2019). Evaluating the impact of policies recommending PrEP to subpopulations of men and transgender women who have sex with men based on demographic and behavioral risk factors. PLoS ONE. 14(9). e0222183–e0222183. 1 indexed citations
16.
Prusiner, Stanley B., Amanda L. Woerman, Daniel A. Mordes, et al.. (2015). Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism. Proceedings of the National Academy of Sciences. 112(38). E5308–17. 542 indexed citations breakdown →
17.
Oldenburg, Catherine E., Prajna Lalitha, Muthiah Srinivasan, et al.. (2013). Moxifloxacin Susceptibility Mediates the Relationship between Causative Organism and Clinical Outcome in Bacterial Keratitis. Investigative Ophthalmology & Visual Science. 54(2). 1522–1522. 23 indexed citations
18.
Wu, Yvonne W., Larry A. Bauer, Roberta A. Ballard, et al.. (2012). Erythropoietin for Neuroprotection in Neonatal Encephalopathy: Safety and Pharmacokinetics. PEDIATRICS. 130(4). 683–691. 152 indexed citations
19.
McQuillen, Patrick S., Shannon E. G. Hamrick, Marta J. Perez, et al.. (2006). Balloon Atrial Septostomy Is Associated With Preoperative Stroke in Neonates With Transposition of the Great Arteries. Circulation. 113(2). 280–285. 144 indexed citations
20.
Flori, Heidi R., David V. Glidden, George W. Rutherford, & Michael A. Matthay. (2004). Pediatric Acute Lung Injury. American Journal of Respiratory and Critical Care Medicine. 171(9). 995–1001. 256 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026